To this end, we utilized PYCR1-IN-1, a chemical inhibitor of PYCR1, and conducted preliminary assessments of its effectiveness in reducing the growth of 3D tumor spheroids derived from lung cancer cells to determine the optimal concentration. Here, PYCR1 is linked to lung carcinoma.